Neurologic Ophthalmology and Otology (R Shin and D Gold, Section Editors)Published:

Update on Therapies for Mal de Débarquement Syndrome

Yoon-Hee Cha MD

Current Treatment Options in Neurology volume 24pages 485–501 (2022)

Abstract

Purpose of Review

This review will discuss current treatment options for mal de débarquement syndrome (MdDS) and non-motion triggered persistent oscillating vertigo (nmPOV). Therapies available in most clinical settings such as modifying homeostatic factors (sleep, stress, menstrual cycle, visual stimulation), medications (benzodiazepines, serotonin reuptake inhibitors), and vestibular/physical therapy are discussed. Travel precautions should incorporate these homeostatic factors and treatment options to minimize exacerbations.

Recent Findings

Recent data on the association between MdDS/nmPOV and vestibular migraine as well as experimental therapies including vestibulo-ocular reflex readaptation and non-invasive brain stimulation including repetitive transcranial magnetic stimulation and transcranial alternating current stimulation will be covered. Emerging ideas of oscillating vertigo as a manifestation of extracranial venous stenosis are proposed as a potential underlying etiology for these rhythmic perceptions, especially in cases occurring in the setting of overuse injury or trauma to the neck and upper chest causing cervical mal-alignment, muscle spasm, and vascular compression.

Summary

MdDS and nmPOV are disorders with high morbidity but can be managed with a combination of homeostatic modifications, medications, and precautions for travel. The evolution of experimental therapies coupled with emerging ideas on a vascular pathogenesis may provide new avenues of treatment not currently employed.